Filters
Hikma receives FDA approval and launches the generic version of Victoza®, Liraglutide, in the US
Press Release, Product
Hikma launches Indomethacin Suppositories in the US
Press Release, Product
Hikma acquires the rights to a portfolio of Takeda brands for the MENA region
Press Release, Product
Fostering connection and compassion: Hikma’s Community Dinner in Portugal
Story, Responsibility
Hikma’s Cherry Hill site wins Governor’s Environmental Excellence Award in the US
Story, Responsibility
Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products
Press Release, Product
Hikma launches Furosemide Injection, USP, in the US
Press Release, Product
Sell-side analysts and investors visit Hikma Casablanca site
Press Release, Corporate
Celebrating Global Biosimilars Week: Hikma champions access to essential medicines for patients in the MENA region
Story, Business Development
Meet Lisa Hurley and learn more about how she champions quality
Story, Responsibility
Meet Nawras A. BnyYassien, Health, Safety, and Environment, Manager for Hikma Chemical and Hikma Jordan. Hear what he ha...
Story, Life at Hikma
Hikma continues strong strategic execution and reiterates guidance
Press Release, Financial Results
Expanding our onsite renewable energy Generation
Story, Responsibility
Hikma's leadership receives prestigious recognitions in 2024
Story, Leadership
Empowering lives - Hikma’s regional blood donation drives across MENA
Story, Responsibility